Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bauknecht

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Cancer Detection and Prevention|January 1, 1994
Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomasT Bauknecht, M Kiechle-Schwarz, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Phase II study of gemcitabine in ovarian cancerG von Minckwitz, T Bauknecht, C M Visseren-Grul, et al.
Zentralblatt Fur Gynakologie|June 17, 2000
[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum]A du Bois, H J Lück, J Pfisterer, et al.
Anticancer Research|July 1, 1991
Expression analysis of EGF-R and TGFa in human ovarian carcinomasT Bauknecht, F Kommoss, G Birmelin, et al.
Archives of Dermatological Research|July 29, 1998
Localization of cytokeratin 10 mRNA in human epidermis using nonradioactive in situ hybridization as a routine methodI Meinhold-Heerlein, T Brandstetter, F Kommoss, et al.
Anticancer Research|July 1, 1997
UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGPU Schwarz-Roeger, B Petzoldt, R Waldschmidt, et al.
Geburtshilfe Und Frauenheilkunde|September 1, 1995
[Effect of pregnancy and labor on serotonin metabolism]A du Bois, C A Schäfer, W Vach, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1996
[Changes in serotonin metabolism in pre-eclampsia]C A Schäfer, A du Bois, W Vach, et al.
Gynecologic Oncology|November 1, 1994
Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomasM Kiechle-Schwarz, T Bauknecht, U Karck, et al.
Genes, Chromosomes & Cancer|May 1, 1996
Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancerN Arnold, L Hagele, L Walz, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Cancer Detection and Prevention|January 1, 1994
Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomasT Bauknecht, M Kiechle-Schwarz, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Phase II study of gemcitabine in ovarian cancerG von Minckwitz, T Bauknecht, C M Visseren-Grul, et al.
Zentralblatt Fur Gynakologie|June 17, 2000
[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum]A du Bois, H J Lück, J Pfisterer, et al.
Anticancer Research|July 1, 1991
Expression analysis of EGF-R and TGFa in human ovarian carcinomasT Bauknecht, F Kommoss, G Birmelin, et al.
Archives of Dermatological Research|July 29, 1998
Localization of cytokeratin 10 mRNA in human epidermis using nonradioactive in situ hybridization as a routine methodI Meinhold-Heerlein, T Brandstetter, F Kommoss, et al.
Anticancer Research|July 1, 1997
UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGPU Schwarz-Roeger, B Petzoldt, R Waldschmidt, et al.
Geburtshilfe Und Frauenheilkunde|September 1, 1995
[Effect of pregnancy and labor on serotonin metabolism]A du Bois, C A Schäfer, W Vach, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1996
[Changes in serotonin metabolism in pre-eclampsia]C A Schäfer, A du Bois, W Vach, et al.
Gynecologic Oncology|November 1, 1994
Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomasM Kiechle-Schwarz, T Bauknecht, U Karck, et al.
Genes, Chromosomes & Cancer|May 1, 1996
Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancerN Arnold, L Hagele, L Walz, et al.
Pageof 10